RGTI · Rigetti Computing, Inc. · Stock research

Current Thesis

The quantum pure-play trade has moved past rolling over into active deflation. RGTI traded $13.41–$14.58 on 2026-07-17 and closed near $14.19, down roughly 27% across July and about 76% below the $58.15 52-week high. The $14 area that had contained the 2026-05-21 CHIPS-stake gap and the 2026-06-22/23 executive-order pop is now the ceiling rather than the floor. What is notable is what the selling is not about: the 2026-07-13 group-wide 6–8% drop came with no company news attached, tracing to a 1.48% QQQ drawdown and a risk-off rotation through the AI and chip complex. When a basket only moves with beta and never on its own headlines, it has stopped being a narrative and become a leveraged proxy for tech risk appetite. Against roughly $7M of trailing revenue on a ~$4.69B cap, that is an expensive way to own beta. There is no company binary until the Q2 print, estimated 2026-08-10 after the close.

Bullish and bearish views on Rigetti Computing, Inc.

The model's bull view on Rigetti Computing, Inc. (RGTI), in brief: C-DAC India contract, $8.4M (announced 2026-02-26): a 108-qubit Cepheus-1-108Q system for India's Centre for Development of Advanced Computing, delivery slated for H2 2026. The bear view: The July tape is a hype-cycle unwind, not a dip. Both cases follow in full.

Bull Case

• C-DAC India contract, $8.4M (announced 2026-02-26): a 108-qubit Cepheus-1-108Q system for India's Centre for Development of Advanced Computing, delivery slated for H2 2026. This is the first sovereign order outside North America and establishes a per-system price reference for the sovereign-procurement thesis that is now the most credible bull leg on the name.
• Q1 2026 (2026-05-11): revenue $4.4M, +198.9% YoY the steepest growth rate in the pure-play group, driven by Cepheus GA and Novera on-prem QPU deliveries. Small base, but the acceleration is real and hardware-backed rather than services-padded.
• $569.0M cash, zero debt (2026-03-31) against roughly $26M/quarter operating burn. About two years of runway removes the near-term forced-dilution scenario that usually breaks names in this cohort during a drawdown.
• Cepheus-1-108Q general availability (April 2026): 99.9% median single-qubit and 99.1% median two-qubit gate fidelity, with a stated 99.5% two-qubit target for 2026, live across Rigetti QCS, AWS Braket, Azure Quantum and qBraid.
• CHIPS Act LOI (2026-05-21, re-reported 2026-07-11): non-binding, up to $100M over three years from Commerce, inside the broader $2B federal quantum program alongside IBM, GlobalFoundries, Quantinuum, PsiQuantum and Infleqtion.
• Un-fired standalone trigger: a first named Fortune-500 Cepheus customer or a formal Nvidia CUDA-Q integration would be a 30%+ event on a float this thin, because it would separate RGTI from the basket.

Bear Case

• The July tape is a hype-cycle unwind, not a dip. RGTI -27%, IONQ -34.1%, QBTS -29% over the month through 2026-07-17. Correlated single-month drawdowns of that size across an entire theme mark distribution, not rotation within it.
• Inverse products are the loudest signal in the group. Benzinga reported 2026-07-17 that IONZ, QBTZ and RGTZ the 2X short single-stock quantum ETFs gained up to 108%. Product issuers only build and market the short side once the long side has already broken.
• Supply keeps arriving into a falling tape. Tradr launched five 2X leveraged single-stock ETFs on 2026-07-01 into a $10B lineup, and Quantinuum's ~$1.5B IPO is pressing toward its Nasdaq debut. Fresh paper into a de-rating theme compresses whatever scarcity premium the incumbents traded on.
• The valuation only worked on velocity. Roughly $4.69B against ~$7M FY2025 revenue (-34% YoY) and $4.4M in Q1 leaves a trailing multiple that requires the narrative to be getting louder every week. It is getting quieter.
• IONQ is showing company-specific damage. It broke below $40 on 2026-07-13 on Pentagon contract-loss rumours. The federal-procurement leg is the shared load-bearing story for the group; if it cracks at the largest name, the smaller ones do not get a pass.
• The policy catalyst has been fully monetised. The 2026-06-22/23 executive orders produced an after-hours pop that faded inside days. A theme that cannot hold a presidential-order bid has exhausted its marginal buyer.

Setup & Price Structure

Structure is broken on every timeframe that matters. Price sits below the 50-EMA and the 50-EMA below the 200-EMA, the stock is roughly 76% off its 52-week high of $58.15, and the $14 shelf that had marked the base of the two 2026 policy gaps gave way in the week of 2026-07-13. The 52-week low at $12.53 is the only structural reference left underneath. Rallies inside July have been sold within a session or two, which is the behaviour of a name being distributed into strength rather than accumulated on weakness. There is no higher low, no volume-backed reclaim, and no base nothing that this playbook recognises as a setup. Averaging into the decline on the strength of the fundamental story is exactly the trap the tape is setting: the cash balance and the fidelity roadmap are both true and neither of them is a bid.

Catalyst Calendar (next 30 days)

• ~2026-08-10 (est., after close) Q2 2026 earnings. One source indicates 2026-08-06; the exact date needs confirming from the next 8-K. This is the only genuine binary in the window. Consensus attention will be on whether the +198.9% Q1 growth rate held and on any Cepheus order-book commentary.
• H2 2026 (no fixed date) C-DAC India 108-qubit delivery. A delivery-confirmation release would be the single most credible company-specific headline available before the print.
• Ongoing, no date Quantinuum Nasdaq debut (~$1.5B raise). The listing itself is a sector-wide repricing event for relative multiples.

Elapsed catalysts

• 2026-07-14 (elapsed) quantum industry showcase on Capitol Hill featuring Nvidia, IBM, Rigetti, Infleqtion and D-Wave. Passed without producing a bid, which is itself the datapoint. _(passed 5d ago)_

What Would Change Our Mind

The read flips constructive on evidence that the group has stopped trading purely as tech beta. Concretely: QBTS reclaiming and holding its 20-EMA on rising volume, followed by RGTI building a higher low above $14 and reclaiming that shelf on a weekly close that sequence would mark a base rather than a bounce. A named Fortune-500 Cepheus-1-108Q customer, a formal Nvidia CUDA-Q integration, or a second sovereign order at or above the $8.4M C-DAC reference price would each be a company-specific re-rate that the basket beta cannot explain away. A Q2 print around 2026-08-10 that holds triple-digit YoY revenue growth and comes with a bookings number would restart the fundamental clock. Absent those, the constructive case has no entry.

Correlation Notes

RGTI trades as the third-liquidity leg of a four-name basket IONQ, QBTS, RGTI, QUBT that moves in near-lockstep on macro days; the 2026-07-13 session had all four down 6–8% simultaneously with zero company news. QBTS is the leading tell for basket direction and IONQ the tell for federal-procurement risk, so both should be read before any RGTI-specific view. Second-order correlation runs to NVDA and the broader AI/chip complex: quantum basket rallies have not sustained on days NVDA closes red, and July's drawdown coincided with QQQ weakness rather than any sector event. Quantinuum's listing adds a new correlated instrument that will likely absorb the marginal institutional quantum dollar. On the short side, the inverse ETF complex (IONZ, QBTZ, RGTZ) now provides a frictionless way for the crowd to express bearishness on individual names, which structurally raises the volatility of any bounce.